Position in ANIP
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,765,596
New position
Shares Held
33,409
first reported quarter
Ownership
0.145%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#94
of 303 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 8%
Shared 92%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NFJ INVESTMENT GROUP, LLC holds $17,481,465 across 5 Drug Manufacturers - Specialty & Generic names. ANIP ranks #4 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
138,777 | $5,694,019 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
218,294 | $3,778,668 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
278,792 | $2,787,920 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
This page
|
33,409 | $2,765,596 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
52,790 | $2,455,262 |
All Filings in ANIP
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,765,596 | 33,409 | Shares | Other | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||